CDC recommends second COVID vaccine dose for those 65 and older
Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...
aha.org2h
AHA receives CDC grant to address opioid, stimulant use disorder and expand infection prevention resources
The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention ...
C.D.C. Expands Covid Vaccine Recommendations
Not everyone, of course, will be willing: Covid vaccine uptake has remained stubbornly low over the last few years. As of Oct ...
Multiomics of HIV non-progressors reveals immunity behind AIDS evasion
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
clinicaltrialsarena1d
IDWeek 2024: Prevention and treatment for HIV – clinical trials and policy challenges
As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...
Success of long-lasting HIV drug hinges on pricing
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Radio Free Europe/Radio Liberty2d
HIV-Infected Patient Refused Care In Armenia
Marine, not her real name, was considering surgery to deal with intense pain. Three doctors refused to see her before a ...
Daily Maverick on MSN3d
Alarming rise in HIV among drug users as government fails to implement policy
Less than half of those who tested positive for HIV in Pretoria were aware of their HIV status. As such they would not have ...
Fred Hutch3d
Infectious disease experts propose trials network dedicated to immunocompromised patients
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
Future Market Insights3d
Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to be valued US$ 62.37 Billion by 2033, at a CAGR of 6%
The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...
Fighting the stigma: A Detroit HIV survivor shares his story to help others with virus
Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
Science Daily4d
HIV and AIDS News
25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...